Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Synthetic double-stranded siRNA oligonucleotide directed against transthyretin mRNA

EU orphan designation number: EU/3/11/857   
Active ingredient: Synthetic double-stranded siRNA oligonucleotide directed against transthyretin mRNA
Indication: Treatment of transthyretin-mediated amyloidosis
Sponsor: Alnylam UK Limited
Braywick Gate, Braywick Road, Maidenhead SL6 1DA, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/04/2011 Orphan designation EMA/OD/142/10 (2011)2844 of 15/04/2011
13/11/2014 Transfer of orphan designation EMA/OD/142/10/T/01 (2014)8536 of 11/11/2014
10/04/2017 Amendment of orphan designation EMA/OD/142/10 (2017)2424 of 06/04/2017
11/10/2017 Change of name and/or address of sponsor